These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26885248)

  • 1. Oxidative Stress Markers in Sputum.
    Antus B
    Oxid Med Cell Longev; 2016; 2016():2930434. PubMed ID: 26885248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
    Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
    Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.
    Antus B; Harnasi G; Drozdovszky O; Barta I
    Respirology; 2014 Jan; 19(1):74-9. PubMed ID: 23834671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
    Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
    Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
    Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
    Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
    Tsoumakidou M; Papadopouli E; Tzanakis N; Siafakas NM
    Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma.
    Louhelainen N; Rytilä P; Obase Y; Mäkelä M; Haahtela T; Kinnula VL; Pelkonen A
    J Asthma; 2008 Mar; 45(2):149-54. PubMed ID: 18350407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases.
    Wood LG; Garg ML; Simpson JL; Mori TA; Croft KD; Wark PA; Gibson PG
    Am J Respir Crit Care Med; 2005 Mar; 171(5):426-30. PubMed ID: 15579724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative and Nitrosative Stress in the Pathogenesis of Obstructive Lung Diseases of Increasing Severity.
    Di Stefano A; Maniscalco M; Balbi B; Ricciardolo FLM
    Curr Med Chem; 2020; 27(42):7149-7158. PubMed ID: 32496983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
    Iwamoto H; Gao J; Koskela J; Kinnula V; Kobayashi H; Laitinen T; Mazur W
    Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
    Malerba M; Ragnoli B; Corradi M
    Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3-nitrotyrosine determination as nitrosative stress marker and health attitudes of medical students considering exposure to environmental tobacco smoke].
    Szumska M; Wielkoszyński T; Tyrpień K
    Przegl Lek; 2012; 69(10):798-802. PubMed ID: 23421035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD.
    Kanazawa H; Yoshikawa J
    Chest; 2005 Nov; 128(5):3191-7. PubMed ID: 16304261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
    Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
    Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
    Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
    Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.